Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15025782 | 0.97 | GRM5 (0.67) | GRM5 | |
| SCHEMBL15025805 | 0.93 | GRM5 (0.71) | GRM5 | |
| SCHEMBL15025904 | 0.88 | GRM5 (0.78) | GRM5 | |
| SCHEMBL15025786 | 0.86 | GRM5 (0.73) | GRM5GRIN2B | |
| SCHEMBL15025899 | 0.86 | GRM5 (0.78) | GRM5 | |
| SCHEMBL15025898 | 0.83 | GRM5 (0.84) | GRM5 | |
| SCHEMBL15115058 | 0.82 | MAPK1 (0.46) | GRM5GRIN2B | |
| SCHEMBL14982314 | 0.81 | MAPT (0.43) | GRM5 | |
| SCHEMBL15034520 | 0.81 | LMNA (0.42) | GRM5 | |
| SCHEMBL15034515 | 0.81 | L3MBTL1 (0.43) | GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846948-B2 | Compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-09-30 | — | — | US | disclosed |
| US-8846948-B2 | Compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-09-30 | — | — | US | disclosed |
| US-20130150355-A1 | NOVEL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| US-20130150355-A1 | NOVEL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150355-A1 | NOVEL COMPOUNDS | GRM5, GRIN2A, GRIN1 | GRM5 1/4885GRIN2B 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.